Read + Share
Su S, Cao J, Meng X, Liu R, et al. Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers
resistance in prostate cancer bone metastases. Cancer Lett 2021 Nov 6. pii: S0304-3835(21)00558.
PMID: 34752846
|
 |
|
Su S, Cao J, Meng X, Liu R, et al. Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers
resistance in prostate cancer bone metastases. Cancer Lett 2021 Nov 6. pii: S0304-3835(21)00558.
PMID: 34752846
|
|
|
|